BSE filing, NSE: ROOPAIND. Summary written from the filing by ALFA Finder's alert engine.
Roopa Industries Ltd: key numbers
- Share price
- ₹42.60
- Market cap
- ₹33.51 Cr
- Revenue (annual)
- ₹127.5 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- 261.6×Sector 46.5×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Roopa Industries Ltd
All →Roopa Industries Other Announcement
Roopa Industries has re-appointed M/s. Yelamanchi & Associates as its Statutory Auditor for a 60-month term, effective October 1, 2026.
Roopa Industries Annual General Meeting
Roopa Industries Limited conducted its 41st Annual General Meeting on September 30, 2026. Shareholders considered resolutions including adoption of financial statements and auditor re-appointments.
Roopa Industries Annual General Meeting
Roopa Industries Limited approved the notice for its 41st Annual General Meeting, scheduled for September 30, 2026, via video conferencing. The company also appointed a scrutinizer.
Roopa Industries Q1 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Roopa Industries Ltd reported revenue from operations of ₹33.3 Cr (-5.1% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY
Roopa Industries Other Announcement
Roopa Industries reported Nil physical share transfer requests for the special window period of July 2026. This is a routine compliance disclosure.
Roopa Industries Board Meeting Date
Roopa Industries Limited has scheduled a board meeting on August 14, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.